The group acknowledges limited growth in South Africa’s price-regulated pharma market but believes Natco’s backing will ...

Natco Pharma shares will be in focus of the stock market investors on Thursday after the ₹2,000 crore acquisition move. The ...

Natco Pharma to acquire 35.75% stake in South Africa’s Adcock Ingram for ₹1,970 crore in cash; move aimed at expanding global ...

Vice Chairman and CEO Rajeev Nannapaneni said the company is looking for another transaction, potentially as large or even ...

Indian pharmaceutical company Natco Pharma Ltd has decided to acquire a 35.75% stake in South Africa’s Adcock Ingram ...

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.

The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

Shares of firms like Infosys, Bajaj Finance, Nestle, IndusInd Bank, Natco Pharma, and others will be in focus on ...

Indian pharmaceutical market saw a late surge in June, with growth during the quarter primarily driven by cardiac, ...

Natco’s proposed all-cash deal to acquire nearly 36% of AIHL from minority shareholders is aimed at expanding its presence in ...

Top Indian companies announce Q1 results, acquisitions, and fundraising plans - discover which stocks to watch and stay updated on market trends now!

A recent history of NIFTY MIDCAP performance shows a volatile performance. It had alternating gains and losses in the past 4 ...